Annovis Bio

Annovis Bio is a clinical-stage company developing drugs for neurodegeneration, such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and other chronic neurodegenerative diseases.

success failure signposts
Biotech

Annovis glosses over primary goal in pivotal Parkinson’s data

Annovis reported success in subgroups and secondary endpoints while skirting the question of whether the candidate moved the needle on the main goal.
Nick Paul Taylor Jul 2, 2024 9:38am
Red graph decrease on black chalkboard

Annovis shares plummet 60% after muddled Alzheimer’s readout

Apr 29, 2024 11:45am